Search Results - E. A. Pyadushkina

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS by E. A. Pyadushkina

    Published in Фармакоэкономика (2017-05-01)
    Get full text
    Article


  2. 2

    CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY by E. A. Pyadushkina, M. Yu. Frolov

    Published in Фармакоэкономика (2016-12-01)
    Get full text
    Article


  3. 3

    Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients by E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov

    Published in Фармакоэкономика (2023-07-01)
    Get full text
    Article


  4. 4

    CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS by E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva

    Published in Фармакоэкономика (2016-02-01)
    Get full text
    Article


  5. 5

    Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults by E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

    Get full text
    Article


  6. 6

    METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY by N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov

    Published in Фармакоэкономика (2016-09-01)
    Get full text
    Article


  7. 7

    Cost-effectiveness analysis of active psoriatic arthritis treatment with ixekizumab in adult patients in Russian Federation health care system by E. A. Pyadushkina, E. V. Derkach, M. Yu. Frolov, V. A. Rogov, A. S. Salasyuk

    Get full text
    Article


  8. 8

    New possibilities for the treatment of systemic lupus erythematosus. How much does the effect cost? by E. A. Pyadushkina, A. M. Lila, E. E. Yagnenkova, V. I. Ignatyeva, E. V. Derkach

    Get full text
    Article


  9. 9

    Comparative pharmacoeconomic analysis of the use of Bonviva® (ibandronat) to prevent fractures in postmenopausal osteoporosis by E A Pyadushkina, K V Gerasimova, S V Goryainov, Vitaly Vladimirovich Omelyanovsky, M V Avksentyeva, I S Krysanov

    Get full text
    Article


  10. 10

    The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups by E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan

    Published in Фармакоэкономика (2020-11-01)
    Get full text
    Article


  11. 11

    Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting by E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov

    Published in Фармакоэкономика (2021-07-01)
    Get full text
    Article


Search Tools: